Edition:
United States

SCYNEXIS Inc (SCYX.OQ)

SCYX.OQ on NASDAQ Stock Exchange Global Market

0.97USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$0.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
66,152
52-wk High
$2.44
52-wk Low
$0.96

Chart for

About

SCYNEXIS, Inc. is engaged in the discovery, development and commercialization of anti-infectives. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of several fungal infections, including serious invasive fungal infections. SCY-078 is a structurally distinct... (more)

Overall

Beta: 0.34
Market Cap(Mil.): $57.36
Shares Outstanding(Mil.): 47.01
Dividend: --
Yield (%): --

Financials

  SCYX.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -0.90 -- --
ROI: -66.81 13.18 12.83
ROE: -105.66 15.14 14.95

BRIEF-Scynexis Q1 Loss Per Share $0.12

* SCYNEXIS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE

May 08 2018

Earnings vs. Estimates